• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM

IMMUTEP LIMITED

2.04% ! 25.0¢
Market Cap $365.0M  !

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMM
Media
4 5 6
07:05 331 167K
07:05 Last post  ahjay Comments Created with Sketch.  331  Views Created with Sketch.  167K 
IMM 25/04/25 7 3.1K
25/04/25 Last post  GreenWave Comments Created with Sketch.  7  Views Created with Sketch.  3.1K 
IMM 23/04/25 71 30K
23/04/25 Last post  Joe007 Comments Created with Sketch.  71  Views Created with Sketch.  30K 
IMM 12/04/25 15 6.1K
12/04/25 Last post  Joe007 Comments Created with Sketch.  15  Views Created with Sketch.  6.1K 
IMM 10/04/25 8 3.4K
10/04/25 Last post  Bsee Comments Created with Sketch.  8  Views Created with Sketch.  3.4K 
IMM 08/04/25 0 395
08/04/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  395 
IMM 03/04/25 0 461
03/04/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  461 
IMM 03/04/25 6 3.7K
03/04/25 Last post  Vivo Comments Created with Sketch.  6  Views Created with Sketch.  3.7K 

See All Discussions arrow Created with Sketch.

Timeline

Immutep Investor Update
23 Apr 10:24
 
Change in substantial holding
11 Apr 08:20
 
Change of Director's Interest Notice - M Voigt
08 Apr 15:32
 
Change of Director's Interest Notice F Triebel
08 Apr 15:31
 
Application for quotation of securities - IMM
03 Apr 14:31
 
Immutep to Participate in Upcoming Investor Conferences
02 Apr 08:31
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
25.0¢
Change
0.005(2.04%)
Mkt cap ! $365.0M
Open High Low Value Volume
24.5¢ 25.5¢ 24.5¢ $730.2K 2.916M

Buyers (Bids)

No. Vol. Price($)
1 8048 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 10000 1
View Market Depth
Last trade - 16.10pm 25/04/2025 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.